Biologics Market Driving Public Health Impact
The vaccines segment of the Biologics Market is set to grow pandemic accelerated innovation, with mRNA technology proving its potential for rapid development. Governments are strengthening immunization programs, especially in emerging markets. North America leads production, while Asia-Pacific shows the fastest growth due to large-scale healthcare investments. Innovations like universal flu vaccines, therapeutic cancer vaccines, and combined immunizations are shaping the segment’s future.
Industry leaders such as Pfizer, Sanofi, and GSK are expanding capacities and partnerships to meet global demand, keeping vaccines a central growth engine for biologics.
3 Views